mirvetuximab,bevacizumab
immunogen,roche
['bevacizumab', 'ovarian', '$imgn']
elahere shows greater survival benefit in ovarian cancer patients not given bevacizumab $imgn #asco23 
The latest global #pharma news, insights, analysis, and views providing you with an information edge.  FirstWord Pharma. Where people who know first, go first.